Enliven Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 262k | 20.47 |
| 2025-03-31 | $4.2M | 212k | 19.68 |
| 2024-12-31 | $3.0M | 131k | 22.50 |
| 2024-09-30 | $3.1M | 122k | 25.54 |
| 2024-06-30 | $1.5M | 66k | 23.37 |
| 2024-03-31 | $304k | 17k | 17.59 |
| 2023-12-31 | $314k | 23k | 13.84 |
| 2023-09-30 | $242k | 18k | 13.66 |
| 2023-06-30 | $557k | 27k | 20.41 |
| 2023-03-31 | $907k | 41k | 21.90 |